Literature DB >> 2539401

Use of betapropiolactone to disinfect fresh tissue without impairing antigenicity: method applicable to human immunodeficiency virus (HIV) positive tissue.

A J Chaplin1, A Heryet, L N Holdsworth, R P Eglin, P R Millard.   

Abstract

A method for inactivating viruses in tissues is reported that does not impair the antigenicity of the Coxsackie virus or of some common tissue antigens, a common problem with standard tissue fixation methods. Tissues can be placed briefly in Betapropiolactone before cryostat sectioning without any adverse effect on preservation or antigen expression. It is suggested that use of Betapropiolactone is applicable to tissues harbouring or exposed to the human immunodeficiency virus (HIV). As betapropiolactone has been reported to be carcinogenic in rodents any potential danger can be avoided by basic simple precautions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539401      PMCID: PMC1141876          DOI: 10.1136/jcp.42.3.318

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  5 in total

Review 1.  CARCINOGENIC LACTONES AND RELATED SUBSTANCES.

Authors:  F DICKENS
Journal:  Br Med Bull       Date:  1964-05       Impact factor: 4.291

2.  The detection of coxsackievirus RNA in cardiac tissue by in situ hybridization.

Authors:  A J Easton; R P Eglin
Journal:  J Gen Virol       Date:  1988-02       Impact factor: 3.891

3.  Effect of beta-propiolactone in blood on routine haematological, biochemical, and serological investigations.

Authors:  R Freeman; A A Codd; J B Selkon
Journal:  Lancet       Date:  1982-05-08       Impact factor: 79.321

4.  Measles virus infection without rash in childhood is related to disease in adult life.

Authors:  T Rønne
Journal:  Lancet       Date:  1985-01-05       Impact factor: 79.321

5.  Effect of beta-propiolactone--an inhibitor of HTLV III/LAV activity--on immunological analyses.

Authors:  M J Ball; V Spriggs; P M Sutton; H Chapel
Journal:  J Immunol Methods       Date:  1986-12-04       Impact factor: 2.303

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.